amprenavir 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
HIV protease inhibitors 200 161814-49-9

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • amprenavir
  • agenerase
  • angenerase
  • samprenavir
; RN refers to (3S-(3R*(1S*,2R*)))-isomer; fosamprenavir is a prodrug
  • Molecular weight: 505.63
  • Formula: C25H35N3O6S
  • CLOGP: 3.29
  • LIPINSKI: 1
  • HAC: 9
  • HDO: 3
  • TPSA: 131.19
  • ALOGS: -4.01
  • ROTB: 11
  • Status: OFM
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
1.20 g O

ADMET properties:

Approvals:

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

Drug Use | Suggest Off label Use Form| |View source of the data|




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

External reference:

Pharmaceutical products:

None

amprenavir